Walgreens to Acquire Rite Aid in $17.2 Billion Deal

Walgreens to Acquire Rite Aid in $17.2 Billion Deal

Walgreens to Acquire Rite Aid in $17.2 Billion Deal • Tuesday, Oct. 27, after the market close, Walgreens Boots Alliance announced an agreement to acquire smaller drugstore chain Rite Aid for $9.4 billion in cash, offering $9 per share in cash, which represents a 48% premium to Rite Aid’s closing price of $6.08 on Monday. Including debt, the deal is valued at $17.2 billion, the company said. • The deal would bring together the #1 and #3 retail pharmacy companies, creating a pharmacy giant with over 13,000 stores and more than $67.1 billion in combined revenue, according to Drug Store News’s Annual PoweRx Industry Rankings. • The combined company would have an especially strong presence in California and New York. The combination is expected to realize cost synergies of at least $1 billion annually. • The boards of both companies have approved the transaction, which must receive Hart-Scott-Rodino approval and is expected to close during the second half of calendar 2016. SELECTED WALGREENS ACQUISITIONS Date Value Acquisition Business Announced (USD Mil.) 27/10/2015 Rite Aid Corp Pharmacy 9,400 28/07/2015 TytoCare Healthcare Technology Undiscl. 10/02/2015 Clinical Holdings Clinical Development Undiscl. 16/10/2014 MedAvail Technologies Pharmacy Kiosk Undiscl. 24/03/2011 drugstore.com Online Pharmacy 409 17/02/2010 Duane Reade Holdings Drugstore 1,100 08/05/2009 31 Drug Fair stores Pharmacy Undiscl. 17/03/2008 Whole Health Management Home Care & Wellness Center Undiscl. 17/03/2008 Take Care Health Systems Healthcare Clinic Undiscl. 02/07/2007 OptionCare Enterprises Home Healthcare Service 850 29/06/2006 Medmark Specialty Pharmacy 140 05/06/2006 Happy Harry's Discount Drugstore Undiscl. 05/07/2006 C&M Pharmacy Pharmacy Undiscl. 16/02/2006 Canadian Valley Medical Solutions Home Care Undiscl. 01/11/2005 Home Pharmacy of California Specialty Pharmacy Undiscl. 04/10/2005 Schraft's A Walgreens Specialty Specialty Pharmacy 850 Pharmacy Source: Bloomberg and company reports DEBORAH WEINSWIG, EXECUTIVE DIRECTOR –HEAD OF GLOBAL RETAIL & TECHNOLOGY [email protected] US: 917.655.6790 HK: 852.6119.1779 CN: 86.186.1420.3016 1 Copyright © 2015 The Fung Group. All rights reserved. Deborah WeinswiG, CPA Executive Director—Head of Global Retail & Technology Fung Business Intelligence Centre New York: 917.655.6790 Hong Kong: 852.6119.1779 [email protected] Filippo Battaini [email protected] Marie Driscoll, CFA [email protected] John Harmon, CFA [email protected] Aragorn Ho [email protected] John Mercer [email protected] Shoshana Pollack [email protected] Kiril Popov [email protected] Jing Wang [email protected] Steven Winnick [email protected] HONG KONG: 10th Floor, LiFung Tower 888 Cheung Sha Wan Road, Kowloon Hong Kong Tel: 852 2300 2470 LONDON: 242-246 Marylebone Road London, NW1 6jQ United Kingdom Tel: 44 (0)20 7616 8988 NEW YORK: 1359 Broadway, 9th Floor New York, NY 10018 Tel: 646 839 7017 FBICGROUP.COM DEBORAH WEINSWIG, EXECUTIVE DIRECTOR –HEAD OF GLOBAL RETAIL & TECHNOLOGY [email protected] US: 917.655.6790 HK: 852.6119.1779 CN: 86.186.1420.3016 2 Copyright © 2015 The Fung Group. All rights reserved. .

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    2 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us